800 related articles for article (PubMed ID: 18433021)
21. MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma.
Yamamoto Y; Kosaka N; Tanaka M; Koizumi F; Kanai Y; Mizutani T; Murakami Y; Kuroda M; Miyajima A; Kato T; Ochiya T
Biomarkers; 2009 Nov; 14(7):529-38. PubMed ID: 19863192
[TBL] [Abstract][Full Text] [Related]
22. The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules.
Rebouissou S; Couchy G; Libbrecht L; Balabaud C; Imbeaud S; Auffray C; Roskams T; Bioulac-Sage P; Zucman-Rossi J
J Hepatol; 2008 Jul; 49(1):61-71. PubMed ID: 18466996
[TBL] [Abstract][Full Text] [Related]
23. miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3.
Fan CG; Wang CM; Tian C; Wang Y; Li L; Sun WS; Li RF; Liu YG
Oncol Rep; 2011 Nov; 26(5):1281-6. PubMed ID: 21725618
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells.
Wei W; Hu Z; Fu H; Tie Y; Zhang H; Wu Y; Zheng X
Oncol Rep; 2012 Aug; 28(2):701-6. PubMed ID: 22664953
[TBL] [Abstract][Full Text] [Related]
25. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1.
Huang J; Wang Y; Guo Y; Sun S
Hepatology; 2010 Jul; 52(1):60-70. PubMed ID: 20578129
[TBL] [Abstract][Full Text] [Related]
26. Analysis of microRNA expression profiling identifies microRNA-503 regulates metastatic function in hepatocellular cancer cell.
Zhou J; Wang W
J Surg Oncol; 2011 Sep; 104(3):278-83. PubMed ID: 21495032
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.
Meng F; Henson R; Wehbe-Janek H; Ghoshal K; Jacob ST; Patel T
Gastroenterology; 2007 Aug; 133(2):647-58. PubMed ID: 17681183
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma.
Li S; Fu H; Wang Y; Tie Y; Xing R; Zhu J; Sun Z; Wei L; Zheng X
Hepatology; 2009 Apr; 49(4):1194-202. PubMed ID: 19133651
[TBL] [Abstract][Full Text] [Related]
29. Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma.
Xie Q; Chen X; Lu F; Zhang T; Hao M; Wang Y; Zhao J; McCrae MA; Zhuang H
Cancer; 2012 May; 118(9):2431-42. PubMed ID: 21989846
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of miR-21 promotes an in vitro metastatic phenotype by targeting the tumor suppressor RHOB.
Connolly EC; Van Doorslaer K; Rogler LE; Rogler CE
Mol Cancer Res; 2010 May; 8(5):691-700. PubMed ID: 20460403
[TBL] [Abstract][Full Text] [Related]
31. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.
Wang C; Song B; Song W; Liu J; Sun A; Wu D; Yu H; Lian J; Chen L; Han J
J Gastroenterol Hepatol; 2011 Nov; 26(11):1630-7. PubMed ID: 21557766
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of miR-432 activates Wnt/β-catenin signaling and promotes human hepatocellular carcinoma proliferation.
Jiang N; Chen WJ; Zhang JW; Xu C; Zeng XC; Zhang T; Li Y; Wang GY
Oncotarget; 2015 Apr; 6(10):7866-79. PubMed ID: 25797263
[TBL] [Abstract][Full Text] [Related]
33. MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA.
Cui M; Wang Y; Sun B; Xiao Z; Ye L; Zhang X
Biochem Biophys Res Commun; 2014 Feb; 444(2):270-5. PubMed ID: 24462768
[TBL] [Abstract][Full Text] [Related]
34. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
[TBL] [Abstract][Full Text] [Related]
35. [Interest of immunohistochemistry for the diagnosis of benign hepatocellular tumors].
Bioulac-Sage P; Balabaud C; Zucman-Rossi J
Ann Pathol; 2010 Dec; 30(6):439-47. PubMed ID: 21167430
[TBL] [Abstract][Full Text] [Related]
36. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma.
Ura S; Honda M; Yamashita T; Ueda T; Takatori H; Nishino R; Sunakozaka H; Sakai Y; Horimoto K; Kaneko S
Hepatology; 2009 Apr; 49(4):1098-112. PubMed ID: 19173277
[TBL] [Abstract][Full Text] [Related]
37. Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice.
Katzenellenbogen M; Mizrahi L; Pappo O; Klopstock N; Olam D; Jacob-Hirsch J; Amariglio N; Rechavi G; Domany E; Galun E; Goldenberg D
Mol Cancer Res; 2007 Nov; 5(11):1159-70. PubMed ID: 18025261
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-200a and -200b mediated hepatocellular carcinoma cell migration through the epithelial to mesenchymal transition markers.
Hung CS; Liu HH; Liu JJ; Yeh CT; Chang TC; Wu CH; Ho YS; Wei PL; Chang YJ
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S360-8. PubMed ID: 22868917
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma.
Varnholt H; Drebber U; Schulze F; Wedemeyer I; Schirmacher P; Dienes HP; Odenthal M
Hepatology; 2008 Apr; 47(4):1223-32. PubMed ID: 18307259
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-22 is down-regulated in hepatitis B virus-related hepatocellular carcinoma.
Shi C; Xu X
Biomed Pharmacother; 2013 Jun; 67(5):375-80. PubMed ID: 23582783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]